351 related articles for article (PubMed ID: 27613562)
1. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
Thompson-Paul AM; Lichtenstein KA; Armon C; Palella FJ; Skarbinski J; Chmiel JS; Hart R; Wei SC; Loustalot F; Brooks JT; Buchacz K
Clin Infect Dis; 2016 Dec; 63(11):1508-1516. PubMed ID: 27613562
[TBL] [Abstract][Full Text] [Related]
2. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
5. Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis.
Soares C; Kwok M; Boucher KA; Haji M; Echouffo-Tcheugui JB; Longenecker CT; Bloomfield GS; Ross D; Jutkowtiz E; Sullivan JL; Rudolph JL; Wu WC; Erqou S
JAMA Cardiol; 2023 Feb; 8(2):139-149. PubMed ID: 36576812
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
9. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
Friis-Møller N; Ryom L; Smith C; Weber R; Reiss P; Dabis F; De Wit S; Monforte AD; Kirk O; Fontas E; Sabin C; Phillips A; Lundgren J; Law M;
Eur J Prev Cardiol; 2016 Jan; 23(2):214-23. PubMed ID: 25882821
[TBL] [Abstract][Full Text] [Related]
10. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan.
Wu PY; Chen MY; Sheng WH; Hsieh SM; Chuang YC; Cheng A; Pan SC; Wu UI; Chang HY; Luo YZ; Yang SP; Zhang JY; Sun HY; Hung CC
J Microbiol Immunol Infect; 2019 Aug; 52(4):549-555. PubMed ID: 31036484
[TBL] [Abstract][Full Text] [Related]
11. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
[TBL] [Abstract][Full Text] [Related]
12. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.
Kelly SG; Wu K; Tassiopoulos K; Erlandson KM; Koletar SL; Palella FJ;
J Acquir Immune Defic Syndr; 2021 Jul; 87(3):971-977. PubMed ID: 33625065
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea.
Kim SB; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Ku NS; Kim HW; Jeong SJ; Han SH; Song YG; Choi JY; Kim JM
Scand J Infect Dis; 2013 Nov; 45(11):855-62. PubMed ID: 23968223
[TBL] [Abstract][Full Text] [Related]
14. Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis.
Yu J; Liu X; Zhu Z; Yang Z; He J; Zhang L; Lu H
Front Cardiovasc Med; 2023; 10():1138234. PubMed ID: 37034346
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
[TBL] [Abstract][Full Text] [Related]
16. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk Estimation Is Suboptimal in People With HIV.
Triant VA; Lyass A; Hurley LB; Borowsky LH; Ehrbar RQ; He W; Cheng D; Lo J; Klein DB; Meigs JB; Grinspoon SK; Plutzky J; Silverberg MJ; LaValley M; Massaro JM; D'Agostino RB
J Am Heart Assoc; 2024 May; 13(10):e029228. PubMed ID: 38761071
[TBL] [Abstract][Full Text] [Related]
18. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
[TBL] [Abstract][Full Text] [Related]
19. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
[TBL] [Abstract][Full Text] [Related]
20. Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data.
Wolfson J; Vock DM; Bandyopadhyay S; Kottke T; Vazquez-Benitez G; Johnson P; Adomavicius G; O'Connor PJ
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
